Sort
21,453 grants matching “tuberculosis”
Novel Methods to Inform HIV/TB Clinical Trial Development
$580,325Rochelle P Walensky · Massachusetts General Hospital · R01 · FY2012 · AI
Data Coordinating Center for Systems Biology Approach to the Mechanisms of TB
$580,245Elizabeth Renata Brown · University Of Washington · R01 · FY2010 · HL
Optimizing vaccine science to improve the outcome of tuberculosis treatment
$580,184Selvakumar Subbian · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$580,139Rochelle P Walensky · Massachusetts General Hospital · R01 · FY2014 · AI
Immune and metabolic dysfunction during aging in human cohorts
$580,104Blanca I Restrepo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · AG
Evaluating health and economic effects of targeted strategies in TB/HIV
$579,864Theodore H Cohen · Yale University · R01 · FY2016 · AI
Community Transmission of Tuberculosis in Urban Africa
$579,860Christopher C. Whalen · University Of Georgia · R01 · FY2012 · AI
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR
$579,810David G Kingston · Virginia Polytechnic Inst And St Univ · U01 · FY2010 · TW
TB Vaccine Candidates Found in Patients' Bodily Fluids and Murine MHC-1 Molecule
$579,709Antonio Campos-Neto · Ada Forsyth Institute, Inc. · R01 · FY2009 · AI
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infection
$579,583Robert Owen Watson · Vanderbilt University Medical Center · R01 · FY2024 · AI
Sex, HIV, and Lung Health Across the Life Course: The Uganda Lung Health Study
$579,474Crystal North · Massachusetts General Hospital · R01 · FY2025 · HL
Clinical Core
$579,410Richard Douglas Moore · Johns Hopkins University · P30 · FY2021 · AI
Chemical Probes of Mycobacteria
$579,261Laura L Kiessling · Massachusetts Institute Of Technology · R01 · FY2023 · AI
Chemical Probes of Mycobacteria
$579,261Laura L Kiessling · Massachusetts Institute Of Technology · R01 · FY2024 · AI
Chemical Probes of Mycobacteria
$579,261Laura L Kiessling · Massachusetts Institute Of Technology · R01 · FY2025 · AI
Chemical Probes of Mycobacteria
$579,261Laura L Kiessling · Massachusetts Institute Of Technology · R01 · FY2022 · AI
Interplay of Transition Metal Homeostasis and Reactive Sulfur Species in Bacterial Pathogens
$579,235David P. Giedroc · Trustees Of Indiana University · R35 · FY2016 · GM
Identify the host genetic determinants of immune response and TB countrol
$579,162Ildiko Vanrhijn · Brigham And Women'S Hospital · U19 · FY2021 · AI
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
$579,083David R Sherman · Rutgers Biomedical And Health Sciences · U19 · FY2024 · AI
Investigation of Indoor Solid Fuel and Kerosene Use as Tuberculosis Risk Factors
$579,056Michael N Bates · University Of California Berkeley · R01 · FY2015 · ES
The role of FENDRR in host defense against Mycobacterium tuberculosis infection
$578,995Yong Cheng · Oklahoma State University Stillwater · R01 · FY2022 · AI
Iron and O2 in the Regulation of P. aeruginosa Virulence
$578,806Michael L. Vasil · University Of Colorado Denver · R37 · FY2010 · AI
Heme and hemoglobin utilization by Mycobacterium tuberculosis
$578,568Michael Niederweis · University Of Alabama At Birmingham · R01 · FY2023 · AI
Impact of a New Molecular TB Test on TB/HIV Outcomes among HIV-Infected Malawians
$578,551Richard E Chaisson · Johns Hopkins University · R01 · FY2015 · AI
Autophagy-based HDT for tuberculosis
$578,453Vojo P Deretic · University Of New Mexico Health Scis Ctr · UH2 · FY2015 · AI